Breast Cancer Trials

Study 1 Description

This is a study for women who have stage 0, stage 1 or stage 2 Breast Cancer with the intention of receiving Radiation Therapy. The study compares Conventional Whole Breast Radiation (usually daily for 6 weeks) with Partial Breast Radiation (twice daily for 1 week).

Study 2 Description

A Phase III Clinical Trial Comparing the Combination of Taxotere/Cytoxan Plus Bevacizumab to Taxotere/Cytoxan Alone and to Taxptere/Adriamycin/Cytoxan, for Women with Node-Positive or High-Risk Node-Negative, HER2-Negative Breast Cancer

Study 3 Description

Study for patient with HER–2 Positive Early Stage Breast Cancer receiving first time chemotherapy treatment with Docetaxel and Cyclophosmamide.

For additional information about Highline's Cancer Care Program, call (206) 439-5577.